Skip to product information

Harvard Psychopharmacology 2025: A Master Class

Harvard Psychopharmacology 2025: A Master Class

Regular price $70.00 USD
Regular price $70.00 USD Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Harvard Psychopharmacology 2025: A Master Class

Harvard Psychopharmacology 2025: A Master Class

Regular price $70.00
Regular price $70.00 Sale price
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Friday, March 28, 2025

    Day One
    7:30-8:00 AM
    Registration
    8:00-8:15 AM
    Welcome Remarks
    Carl Salzman, MD; Matcheri Keshavan, MD

    8:15-9:00 AM
    Update on the Neurobiology for the Practicing Clinician: Understanding Brain Function and its Clinical Relevance
    Matcheri Keshavan, MD

    9:00-9:45 AM
    Treatment-Resistant Depression: Update on New Antidepressants, Polypharmacy, Augmentation Strategies, Ketamine, Psychedelics, and ECT 
    Alan Schatzberg, MD

    9:45-10:30 AM
    Treatment of Bipolar Disorders; Neurobiology and Clinical Directions; Revival of Lithium
    Roscoe Brady, MD

    10:30-10:45 AM
    Coffee Break
    10:45-11:30 AM
    Update: The Psychopharmacology of the Reproductive Life Cycle: Premenstrual, Pregnancy, Lactation, and Menopause
    Kristina Deligiannidis, MD

    11:30 AM-12:15 PM
    Psychopharmacologic Approaches in Childhood Affective Disorders
    Melissa Delbello, MD, MS

    12:15-12:45 PM
    Panel Discussion #1
    Roscoe Brady, MD; Matcheri Keshavan, MD; Alan Schatzberg, MD; Kristina Deligiannidis, MD; Melissa Delbello, MD, MS

    12:45-1:45 PM
    Lunch 
    1:45-2:30 PM
    Clinical Relevance of Brain Circuity for Psychiatric Treatment
    Roscoe Brady, MD

    2:30-3:15 PM
    Psychopharmacology in Geriatrics and Neuropsychiatry
    Alejandro (Danny) Mendoza, MD

    3:15-3:30 PM
    Coffee Break
    3:30-4:15 PM
    Therapeutic Approaches to the Difficult Patient
    Stephen Stahl, MD, PhD, DSc (Hon)

    4:15-5:00 PM
    Panel Discussion #2
    Roscoe Brady, MD; Alejandro (Danny) Mendoza, MD; Stephen Stahl, MD, PhD, DSc (Hon)

    Saturday, March 29, 2025

    Day Two
    8:30-9:15 AM
    Treatment for Schizophrenia: Prodrome First Episode, Relapse and New Treatment Possibilities
    Matcheri Keshavan, MD

    9:15-10:15 AM
    Neurobiology and Treatment of Sleep in Psychiatric Disorders
    John Winkelman, MD; Tony Cunningham, PhD

    10:15-10:30 AM
    Coffee Break
    10:30-11:15 AM
    Update: Digital Phenotyping in Psychiatry and Psychopharmacology; Role of AI?
    John Torous, MD, MBI

    11:15 AM-12:00 PM
    Clinical Use for Psychedelics? Use for PTSD?
    Ryan Henner, MD

    12:00-12:45 PM
    Panel Discussion #1
    Carl Salzman, MD; John Torous, MD, MBI; John Winkelman, MD; Ryan Henner, MD; Tony Cunningham, PhD

    12:45-1:45 PM
    Lunch 
    1:45-2:30 PM
    Update: Effective Treatment of Substance Use Disorders
    Kevin Hill, MD

    2:30-3:15 PM
    Treatment of Anxiety Spectrum Disorders, and PTSD, New Benzodiazepine Data
    Carl Salzman, MD

    3:15-3:30 PM
    Coffee Break
    3:30-4:15 PM
    Psychopharmacology of Trauma Related Disorders
    Charles Nemeroff, MD, PhD

    4:15-4:45 PM
    Panel Discussion #2
    Carl Salzman, MD; Charles Nemeroff, MD, PhD; Matcheri Keshavan, MD; Kevin Hill, MD

    4:45-5:00 PM
    Wrap-Up, Last Questions